(Q53158179)

11 May 2018

title

International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. (English)

1 reference

11 May 2018

0 references

2

1 reference

11 May 2018

author name string

Jeffrey S Wefel

series ordinal

1

1 reference

11 May 2018

Tim Ahles

series ordinal

3

1 reference

11 May 2018

Sanne B Schagen

series ordinal

4

1 reference

11 May 2018

publication date

25 February 2011

1 reference

11 May 2018

Lancet Oncology Commission

published in

1 reference

11 May 2018

volume

12

1 reference

11 May 2018

page(s)

703-708

1 reference

11 May 2018

issue

7

1 reference

11 May 2018

Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Cognitive function in breast cancer patients receiving adjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Cancer as a risk factor for long-term cognitive deficits and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Cognitive functioning in breast cancer survivors: a controlled comparison

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Cognitive impairment associated with adjuvant therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

A Prospective, Longitudinal Study of the Functional Status and Quality of Life of Older Patients with Breast Cancer Receiving Adjuvant Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Cognitive impairments associated with breast cancer treatments: results from a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Prechemotherapy alterations in brain function in women with breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Adjuvant chemotherapy for breast cancer: effects on cerebral white matter seen in diffusion tensor imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Regional brain activation during verbal declarative memory in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Neuropsychological sequelae of non-central nervous system cancer and cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Neurocognitive changes in cancer survivors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Cognitive dysfunction in people with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Cognitive toxicity of pharmacotherapeutic agents used in social anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

SSRIs and cognitive performance in a working sample.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Paced auditory serial-addition task: a measure of recovery from concussion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Practice effects during repeated administrations of memory tests with and without alternate forms.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Clinical significance: A statistical approach to defining meaningful change in psychotherapy research

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Detecting significant change in neuropsychological test performance: a comparison of four models

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Individual variation for cognitive decline: quantitative methods for describing patterns of change

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

Measuring neuropsychological change following breast cancer treatment: an analysis of statistical models.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970294-1

7 January 2021

10.1016/S1470-2045(10)70294-1

Identifiers

DOI

1 reference

11 May 2018

PubMed ID

21354373

1 reference

11 May 2018